Lv3
382 积分 2022-07-31 加入
Foundation model-enhanced multimodal survival prediction in glioblastoma across multi-institutional cohorts
15天前
已完结
A global, randomized, double-blinded, phase 3 trial of vorasidenib vs placebo in patients with grade 2 glioma with an IDH1/2 mutation (INDIGO): Updated efficacy and safety
1个月前
已关闭
The role for surgery in IDH-mutant grade 4 Astrocytomas: interactive effects of resection, patient characteristics, and outcome - report of the RANO resect group
1个月前
已完结
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response
1个月前
已完结
Exploring the landscape of targetable alterations in patients with glioblastoma
1个月前
已完结
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU)
1个月前
已完结
Cellular and signalling mechanisms that regulate the blood–brain barrier
1个月前
已完结
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
2个月前
已完结
Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas
2个月前
已完结
BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
2个月前
已完结
皖公网安备34019202002308
